Discontinuation report LORAZEPAM

Last updated on 2022-02-06 History
Report ID 144029
Drug Identification Number 02351099
Brand name LORAZEPAM
Common or Proper name LORAZEPAM
Company Name SANIS HEALTH INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LORAZEPAM
Strength(s) 2.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05BA
ATC description ANXIOLYTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-02-05
Remaining supply date
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-02-06 English Compare
v2 2021-08-12 French Compare
v1 2021-08-12 English Compare

Showing 1 to 3 of 3